Photo: X / NYSE
News·
The sell-off has spread to the Dow. Brent has approached its peak since the start of the war with Iran
PhillipCapital upgraded its recommendation on SpaceX shares from “sell” to “buy” amid growth in the company’s revenue from its AI division / Photo: X / SpaceX
News·
An analyst has shifted from a "bearish" view on SpaceX stock to a "bullish" one. What has changed?
Meta’s market capitalization has fallen 9% in five trading days / Photo: PJ McDonnell / Shutterstock.com
News·
Wall Street is split on Meta’s outlook. Should investors buy the current dip?
All signs point to further military escalation in the Middle East in the near term, according to an RBC analyst / Photo: Vova Shevchuk / Shutterstock
News·
Brent crude jumps above $117 for first time since April
News·
GM is on track for its worst week since the start of 2025. Should you buy shares on the dip?
News·
Morgan Stanley picks 24 AI infrastructure stocks built to weather spending slowdown
News·
Apple surpassed Nvidia during trading and became the world's most valuable company
News·
U.S. equities slide at the open on Friday as Brent crude tops $115
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Regulators have agreed to review Biohaven’s application for approval of an experimental treatment for a rare disease that causes a gradual loss of muscle control / Photo: Facebook / Biohaven
Small Caps·
Biohaven soars 25% as drug moves closer to approval. Is there more upside?
Small Caps·
Defense stocks are sliding despite rising orders. What should investors do?
Small Caps·
Lycia IPO: Food allergy biotech cofounded by Nobel laureate debuts on the Nasdaq
Small Caps·
Motley Fool: Six next-generation tech stocks not to forget amid the Anthropic IPO
Small Caps·
AI needs power and computing capacity: Three Griffin holdings with up to 400% upside
Go to section

Investment and Finance News